Clinical Trials Logo

Traumatic Brain Injury (TBI) clinical trials

View clinical trials related to Traumatic Brain Injury (TBI).

Filter by:

NCT ID: NCT01956136 Completed - Clinical trials for Traumatic Brain Injury (TBI)

Efficacy and Neural Basis of Music-based Neurological Rehabilitation for Traumatic Brain Injury

MUBI
Start date: March 2014
Phase: N/A
Study type: Interventional

Traumatic brain injury (TBI) is one of the leading causes of serious, life-long disability among adolescents and young adults. Especially the cognitive, emotional, and motors deficits caused by TBI often impair everyday psychosocial functioning, quality of life and ability to work. The purpose of the study is to determine the long-term effect of music-based rehabilitation on cognitive, motor, emotional, and social recovery after TBI in adolescents and young adults, and to study the neural mechanisms that underlie behavioural recovery and the efficacy of music.

NCT ID: NCT01942564 Completed - Head Injury Clinical Trials

The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study

HIPP
Start date: August 2013
Phase: N/A
Study type: Observational

After a head injury, many people find that exposure to light causes them increased discomfort. By measuring how the pupil in the eye constricts to flashes of red and blue light, this study will investigate whether this phenomenon is due to a change in the eye's sensitivity to light.

NCT ID: NCT01760785 Completed - Alcoholism Clinical Trials

Valproate for Mood Swings and Alcohol Use Following Head Injury

Start date: September 2008
Phase: N/A
Study type: Interventional

Successful treatment of traumatic brain injury (TBI)-induced mood lability may reduce or eliminate drinking behaviors in persons with alcohol abuse/dependence (AA/D) and affective lability following TBI. Observed clinically, the symptoms of poorly regulated affective expression of AA/D+TBI patients who reach alcohol abstinence do not appear to be those of an idiopathic mood or anxiety disorder. These symptoms do not present the severity or the same natural courses as do Major Depressive Disorder, Bipolar Illness, or Anxiety Disorder, for example. Instead, both symptoms and course appear more characteristic of the sustained affect lability often observed following TBI. This observation suggests that TBI survivors represent a patient group for whom treatment of neuropsychiatric symptoms following TBI may alleviate both TBI-related affect lability and also heavy ethanol use by treating the condition that is contextually related to excessive alcohol use. Based on this concept of consequently treating AA/D through the management of post-TBI affective lability, this study was conducted observing the efficacy of divalproex sodium on the severity of affective lability and AA/D in persons suffering from a moderate TBI. Divalproex sodium has been shown to ameliorate mood disorders, even in those with substance abuse problems. This drug has also shown positive results as an alternate medication to benzodiazapines in the treatment of alcohol withdrawal, significantly reducing the progression of withdrawal symptoms in patients.

NCT ID: NCT01750268 Completed - Clinical trials for Traumatic Brain Injury (TBI)

Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI

VAT
Start date: November 2012
Phase: Phase 4
Study type: Interventional

The goal of the proposed project is to improve the treatment of veterans with co-occurring traumatic brain injury (TBI) and hazardous or harmful alcohol use. The PI and coinvestigators will conduct a pilot controlled clinical trial of topiramate for the treatment of these co-occurring disorders.

NCT ID: NCT01547780 Completed - Healthy Clinical Trials

Translocator Protein and Inflammation After Traumatic Brain Injury

Start date: January 20, 2012
Phase: Phase 1/Phase 2
Study type: Interventional

Background: - People with traumatic brain injury (TBI) often have inflammation in the brain. A protein called the translocator protein (TSPO) is often present with inflammation. Researchers want to see if a radioactive chemical known as [11C]PBR28 can be used to study TSPO and inflammation in the brain of people with TBI. Objectives: - To test whether [11C]PBR28 can be used to study changes in the brain after a traumatic brain injury. Eligibility: - Individuals at least 18 years of age who have had TBI and have had a brain scan that shows signs of inflammation. - Healthy volunteers at least 18 years of age. Design: - Participants will be screened with a physical exam and medical history. Blood and urine samples will be collected. - All participants will have two brain scans during an outpatient visit. A magnetic resonance imaging scan will study brain activity. A positron emission tomography (PET) scan will use [11C]PBR28 to look for signs of TSPO and brain inflammation. - Participants with TBI will have two PET scans within 10 days of the head injury, and a PET scan around 90 days after the injury. They may also have MRI scans under this or another study. Tests of thinking, memory, and concentration will be used to study the effects of the injury and inflammation

NCT ID: NCT01118195 Completed - Clinical trials for Traumatic Brain Injury (TBI)

Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans

Start date: January 2007
Phase: N/A
Study type: Observational

This is a study to learn more about traumatic brain injury (TBI) and suicidal behaviors. The purpose of this research is to find out more about the issues related to these conditions. This study seeks to explore the relationship between executive dysfunction and suicidal behavior in an outpatient population.